Investor Resources

Quick Explore

Investor Resources Results for 2022-2023
Cipla Announces Launch Of Leuprolide Acetate Injection Depot (22.5mg)
29th Nov 2022
Update on USFDA inspection at Cipla's manufacturing facility in Goa
24th Nov 2022
Allotment of 23,935 equity shares under ESOS 2013-A Scheme and Cipla ESAR Scheme 2021 of the Company
21st Nov 2022
Disclosure of the related party transactions for the half year ended 30th September 2022
18th Nov 2022
Earnings Call Transcript Q2FY23
04th Nov 2022
Audio recording of earnings conference call for the quarter ended 30th September 2022
04th Nov 2022
Cipla Q2 FY23 Earnings Call Audio
04th Nov 2022
Grant of Stock options and employee stock appreciation rights
04th Nov 2022
Extract of Unaudited Consolidated Financial Results-30th September 2022
04th Nov 2022
Update on Project Clap
04th Nov 2022
 
BSE and NSE Quotes by TradingView

The displayed data is not in real time and may have streaming delays.